Homeo AI vs Dr. Senan RepertoAI: Confidence Scores or Review Copilot?

Quick answer

Choose Dr. Senan RepertoAI when the main job is an AI-led repertorisation environment that accepts natural-language or structured symptoms, cross-references Kent and Boericke, applies its own symptom hierarchy and constitutional analysis, and returns ranked remedy suggestions with confidence scores. Choose Homeo AI when the main job is to keep the practitioner's approved narrative central while reviewing proposed symptoms, rubric mappings, linked source passages, remedy differences, and follow-up changes.

RepertoAI's current product page presents a broad professional platform, including case records, practice analytics, and a practitioner community. It is therefore more than a single remedy finder. Homeo AI's comparison role is narrower: it is a reviewable case copilot, not a substitute for a clinic management suite or a claim to reproduce RepertoAI's ranking method.

As reviewed on 6 August 2026, the RepertoAI page displayed a Starter offer at INR 0 per month for 30 days and then INR 999 per month, a Professional plan at INR 1,799 per month including tax, and Premium or Medical Center pricing by sales contact. Prices can change, so preserve a dated screenshot or written quote and confirm renewal, user limits, taxes, cancellation, and data terms before purchase.

What RepertoAI currently sells

The official page says users can enter symptoms in natural language or a structured form. The system cross-references the Kent and Boericke repertories, weighs symptom hierarchy and constitutional analysis, and produces ranked remedy suggestions with confidence scores. It also offers materia medica details and differential comparisons.

The broader platform description includes patient histories, follow-up tracking, practice analytics, document upload, access across desktop and mobile devices, and community learning. The Professional plan is presented with unlimited AI repertorisation, complete repertory access, case management, analytics, and priority support. A buyer should verify what unlimited means under the current contract and whether model, storage, or fair-use limits exist elsewhere.

The page shows vendor metrics including more than 50,000 cases analysed, more than 2,400 remedies, use in twelve countries, and 94 percent satisfaction. These are vendor claims, not independent validation of remedy accuracy, clinical outcomes, repertory coverage, or user satisfaction. Ask for the definitions, measurement period, sample, exclusions, and source before using them in a procurement decision.

Where RepertoAI is genuinely strong

Its clearest strength is a visible, product-specific repertorisation proposition. The vendor tells a practitioner which repertories are named, which forms of input are accepted, and what type of ranked output to expect. A clinic can build a focused trial around those claims rather than testing an undefined AI assistant.

Confidence scores may help prioritize review if the score is explained and stable. The score should never be read as a probability that a remedy is clinically correct. During a trial, ask whether it reflects rubric coverage, proprietary weighting, model confidence, or another calculation. Repeat the same case after minor wording changes and record whether the order and score move for understandable reasons.

Case management and analytics may also appeal to a practitioner who wants fewer separate systems. That breadth creates a larger governance task. The buyer must verify which functions are available on each plan, how clinic roles are separated, how records leave the system, and whether community features can expose content beyond the intended clinic.

How Homeo AI differs

Homeo AI begins with a narrative that the practitioner can inspect and approve. It proposes a symptom interpretation and rubric mapping, links supporting source passages, and presents remedy differentiation for correction. The practitioner can reject a symptom, change a rubric, inspect the cited material, and retain the rationale for follow-up.

That workflow puts auditability ahead of a single ranked answer. A confidence-ranked list may be efficient, but the practical safety question is whether another practitioner can see why each symptom and source affected the ranking. Homeo AI should be tested on that visible chain. RepertoAI should be tested on the traceability and stability of its confidence scores, named repertory references, and differentials.

The distinction is also commercial. RepertoAI publicly displays a free opening period and recurring Indian prices, plus higher tiers that require a sales conversation. Homeo AI should be costed for its own current plan and workflow. Do not infer price parity or feature parity from the word AI.

The public privacy gap needs a written answer

RepertoAI's current product page explicitly advertises patient histories, document upload, and follow-up tracking. The linked Dr. Senan privacy page is a broad, undated policy. It says collected information may include identity, contact details, age, occupation, interests, financial information, user content, and device or internet data. It also describes uses that can include service delivery, advertising, marketing, and disclosure to related companies, service providers, or contracted third parties.

The public policy does not specifically explain RepertoAI prompt content, model providers, subprocessors, hosting region, clinical-record retention, backup deletion, or whether case material is used to train or evaluate models. The terms say the service is for physicians, does not provide medical advice, and requires users to confirm tools with other sources and exercise clinical judgment. Those limits do not replace a product-specific data agreement.

Before entering any identifiable information, ask for the current RepertoAI privacy notice, terms, data-processing agreement, subprocessor list, hosting locations, encryption details, role permissions, incident process, retention schedule, deletion procedure, model-training rule, and complete export format. Ask whether community and analytics functions use case content. Make the contract, interface, and support answer agree.

Until that review is complete, use only completed, de-identified cases. Remove names, dates of birth, addresses, contact details, record numbers, images, precise locations, and unusual combinations that could identify a person.

A reproducible clinic test

Select six completed, de-identified cases previously reviewed by the same practitioner. Include two straightforward cases, two close differentials, one follow-up, and one case with deliberately incomplete information. Write the expected review steps before opening either product.

In RepertoAI, enter each case first as natural language and then through the structured form. Record the interpreted symptoms, rubric references, weighting, confidence scores, differentials, source details, correction controls, and export. Repeat two cases with harmless wording changes. Check whether confidence changes are stable and explainable. Count every result that cannot be traced to a visible repertory or materia medica passage.

In Homeo AI, enter the same de-identified narratives. Record every proposed symptom and rubric accepted, changed, or rejected. Open the linked passages, inspect the remedy comparison, correct errors, and test whether the follow-up preserves the prior reasoning.

Score both products on total correction time, unsupported claims caught, source traceability, repeatability, role controls, export completeness, and one-year cost at the clinic's actual account and case volume. Do not score agreement with a historical prescription as proof of accuracy. A retrospective match can be produced for the wrong reason.

Known limits and clinical responsibility

A confidence score is not clinical certainty. A high rank can hide an unsuitable rubric, missing qualifier, incomplete history, or opaque weight. Named repertories do not prove the correct edition, attribution, or interpretation. Practice analytics do not prove better patient outcomes.

Homeo AI can also misunderstand a narrative, suggest a weak rubric, miss relevant evidence, or create a plausible differential that needs correction. Linked passages and edit controls improve review; they do not make the output clinically correct.

Neither product replaces diagnosis, referral, an emergency-care decision, practitioner judgment, prescription, potency, dosage, or follow-up responsibility. Urgent symptoms require appropriate conventional assessment, not another software pass. The practitioner remains accountable for every accepted symptom, rubric, source, and clinical action.

Conditional verdict

Choose RepertoAI if the clinic specifically wants confidence-ranked Kent and Boericke repertorisation, values its case and practice modules, and receives satisfactory written answers about the ranking logic, patient-data contract, export, and recurring plan.

Choose Homeo AI if the priority is an inspectable case-review chain from narrative to corrected rubrics, linked passages, differential, and follow-up. If ranked analysis and an audit trail are both important, run the same de-identified case set through both. Buy only after the measured review burden, data boundary, traceability, exit path, and total cost are clear.

Official sources checked

• Dr. Senan RepertoAI official product and pricing page
• Dr. Senan official privacy policy
• Dr. Senan official terms and conditions

Product facts reviewed 2026-08-06. Confirm current features, prices, source libraries, and terms with the vendor.